Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095 |
Resumo: | Cancer has the potential to induce hypercoagulable states. On the other hand, venous thromboembolism may be the harbinger of an occult cancer, may represent a complication of known malignant disease or complicate hospitalization, surgery or various systemic treatments. The importance of venous thromboembolism in patients with cancer is often underestimated resulting in under-diagnosis, which may lead to significant morbidity and mortality. However, many cancer patients do not receive prophylaxis and suitable treatment for venous thromboembolism. The author make some considerations on this disease by addressing the interest and the objectives of the clinical trial CATCH and use of sodium tinzaparin. |
id |
RCAP_bf1781085ddea86968b489390ce8a6f3 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/4095 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical TrialCancro e Trombose Venosa Profunda: a Propósito do Ensaio Clínico CatchCancer has the potential to induce hypercoagulable states. On the other hand, venous thromboembolism may be the harbinger of an occult cancer, may represent a complication of known malignant disease or complicate hospitalization, surgery or various systemic treatments. The importance of venous thromboembolism in patients with cancer is often underestimated resulting in under-diagnosis, which may lead to significant morbidity and mortality. However, many cancer patients do not receive prophylaxis and suitable treatment for venous thromboembolism. The author make some considerations on this disease by addressing the interest and the objectives of the clinical trial CATCH and use of sodium tinzaparin.O cancro tem o potencial de induzir estados de hipercoagulabilidade. Por outro lado, o tromboembolismo venoso pode ser o prenúncio de um cancro oculto, pode representar uma complicação de uma doença oncológica já conhecida ou complicar uma hospitalização, cirurgia ou os vários tratamentos sistémicos. A importância do tromboembolismo venoso para os doentes com cancro é frequentemente subestimado resultando em subdiagnóstico, o que pode conduzir a morbilidade e mortalidade significativas. No entanto, muitos doentes oncológicos não recebem a profilaxia e o tratamento apropriados para a tromboembolismo venoso. O autor faz algumas considerações sobre esta patologia, abordando o interesse e os objectivos do ensaio clínico CATCH e da utilização da tinzaparina sódica. Palavras-chave: Neoplasias; Trombose Venosa ProfundaOrdem dos Médicos2013-05-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095oai:ojs.www.actamedicaportuguesa.com:article/4095Acta Médica Portuguesa; Vol. 26 No. 2 (2013): March-April; 83-85Acta Médica Portuguesa; Vol. 26 N.º 2 (2013): Março-Abril; 83-851646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095/3231Araújo, Antónioinfo:eu-repo/semantics/openAccess2022-12-20T11:03:15Zoai:ojs.www.actamedicaportuguesa.com:article/4095Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:18:41.463319Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial Cancro e Trombose Venosa Profunda: a Propósito do Ensaio Clínico Catch |
title |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial |
spellingShingle |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial Araújo, António |
title_short |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial |
title_full |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial |
title_fullStr |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial |
title_full_unstemmed |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial |
title_sort |
Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial |
author |
Araújo, António |
author_facet |
Araújo, António |
author_role |
author |
dc.contributor.author.fl_str_mv |
Araújo, António |
description |
Cancer has the potential to induce hypercoagulable states. On the other hand, venous thromboembolism may be the harbinger of an occult cancer, may represent a complication of known malignant disease or complicate hospitalization, surgery or various systemic treatments. The importance of venous thromboembolism in patients with cancer is often underestimated resulting in under-diagnosis, which may lead to significant morbidity and mortality. However, many cancer patients do not receive prophylaxis and suitable treatment for venous thromboembolism. The author make some considerations on this disease by addressing the interest and the objectives of the clinical trial CATCH and use of sodium tinzaparin. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-05-31 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095 oai:ojs.www.actamedicaportuguesa.com:article/4095 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/4095 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095/3231 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 26 No. 2 (2013): March-April; 83-85 Acta Médica Portuguesa; Vol. 26 N.º 2 (2013): Março-Abril; 83-85 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130638421327872 |